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Telehealth has become increasingly prominent during the COVID-19 pandemic,
highlighting limitations in access to care for older adults less fluent in information
technology (IT). Although the 20 percent disparity in IT use between younger and
older adult cohorts remains unchanged over several decades, insurers, institutional
and independent providers of health care have made increasing use of IT for patient
communication. Data demonstrate an age-related decline in the frequency of IT use
for accessing health care. Restrictions on reimbursement for the use of the tele-
phone for accessing health care during the COVID-19 pandemic are discussed as a
barrier to access to care. Recommendations are made for assessment of media most
available to older adults for accessing health care, as well as providing funding to
support increased access to care.
Keywords: COVID-19, older adults, access to health care, information technology
(IT), FACETS
1. Introduction
The COVID-19 virus (SARS-CoV-2) was first identified in December of 2019
[1]. COVID-19 spread rapidly, and by the end of January 2020, the World Health
Organization (WHO) had officially labeled the COVID-19 outbreak a pandemic [2].
At risk populations were soon identified, including older adults [3–6]. In an effort to
contain the growth of the contagion, in early 2020 shelter in place practices were
adopted in many countries, forcing the closure of routine businesses including
schools, restaurants, and outpatient healthcare facilities [7–11]. Patient care rapidly
shifted to virtual contact using telehealth platforms including internet-based video-
conferencing software [12]. In the United States (US), the Center for Medicare and
Medicaid Services (CMS) made changes liberalizing standards allowing reimburse-
ment for videoconferencing telehealth, increasing access to care [13, 14]. However,
the rapid shift to telehealth brought to the forefront an access to care issue that had
been simmering for some time: compared with younger age cohorts, most adults
over the age of 65 make limited use of information technology (IT) [15–18]. The
intersection of the rapid growth of telehealth, age-related declines in IT utilization,
and access to care is a growing area of concern for the health care systems with
strong implications for the future of healthcare delivery.
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2. COVID-19: background and description
In December of 2019, a new coronavirus was identified in Wuhan, China. Based
on symptom presentation, it was called SARS-CoV-2, and based on the date of
identification was later called COVID-19. COCVID-19 spread rapidly. On January
30, 2020 the World Health Organization (WHO) officially declared COVID-19 a
public health emergency of international concern, assigning it the status of a pan-
demic [2]. The first identified symptoms of COVID-19 included fever, cough,
fatigue, dyspnea, sore throat, headache, conjunctivitis and gastrointestinal issues.
Loss of the senses of smell and taste were soon added to the symptom list. More
severe reactions included acute respiratory failure and death [10]. Disproportionate
severe acute respiratory symptoms appeared in patients with cardiovascular
comorbidities [19–21], which were eventually understood as a consequence of
SARS-CoV-2 infecting the host using the angiotensin converting enzyme 2 (ACE2)
receptor [22], which is expressed in several organs, including the lung, heart,
kidney, and intestine, as well as endothelial cells [23]. It was found that SARS-CoV-
2 can directly infect engineered human blood vessel organoids in vitro, and vascular
derangements in COVID-19 might reflect endothelial cell involvement by the
virus [22].
2.1 COVID-19: epidemiology and treatment
COVID-19 transmission appears to occur primarily from direct person to person
contact, but infection can also occur through contact with contaminated environ-
mental surfaces. Hand hygiene, wearing personal protective equipment (especially
masks covering the nose and mouth) and maintaining social distance (of at least six
feet) were soon recommended. COVID-19 testing rapidly evolved using nasal swab,
tracheal aspirate or bronchoalveolar lavage samples [11]. A variety of interventions
have been employed, but as of the time of this writing, there are no clinically
approved vaccines or specific therapeutic drugs available for COVID-19, and quar-
antine is the only intervention that appears to be effective in decreasing the conta-
gion rate [7–11]. COVID-19 is currently treated with available antiviral drugs, and
in severe cases, supportive care including oxygen and mechanical ventilation
[24, 25].
The genetic structure, pathogenic mechanism, and clinical characteristics of
COVID-19 have been studied extensively [26, 27]. Vaccination against COVID-19 is
widely believed to be the most promising path to resolution of the pandemic [28].
Having proven effective against similar coronaviruses SARS-CoV and MERS-CoV,
monoclonal antibody vaccination is being pursued by a number of laboratories
[29–33].
2.2 COVID-19: psychological impact
In addition to the physical threat posed by COVID-19, the pandemic has also had
a significant worldwide psychological impact. During the initial stage of the CoViD-
19 pandemic, acute psychological reactions were observed among the general pop-
ulation, healthcare workers, clinical populations, and other at risk groups [34–36].
Psychological triage has long been recognized as an essential care component
before, during and after emergencies and disasters [12, 37]. Care delivery during the
COVID-19 pandemic has been complicated by efforts to shelter in place and
minimize personal interactions, leading to a rapid increase in the utilization of
telehealth [12].
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As the duration of the pandemic grew, increased autonomic arousal in response
to fear of contagion soon translated to chronic stress, with consequent elevation in
adrenaline and cortisol production, activation of the amygdala, and consequent
suppression of activity in the pre-frontal lobe, impairing judgment and impulse
control [38–41]. Stress resulting from the effects of the disease itself was multiplied
by extended periods of social isolation, further complicated by what has been called
an “infodemic:” around the clock news about the pandemic, distributed not only by
news media, but also by social media. The widespread use of social media also
provided a platform for unprecedented expression of racism, stigmatization, and
xenophobia. The intense psychological impact of these combined factors has pro-
duced acute panic, anxiety, obsessive behaviors, hoarding, paranoia, and depres-
sion, and post-traumatic stress disorder (PTSD) [42].
Populations especially at risk for chronic stress related to COVID-19 include
frontline healthcare workers who are at higher risk than other for contracting the
disease, and are prone to burnout, anxiety, fear of transmitting infection, feelings of
incompatibility, depression, increased substance-dependence, and PTSD. Along
with psychiatric patients and marginalized communities, children isolated by school
closures and parents responsible for additional child care during school hours, as
well as assisting children with distance learning have also been identified as at-risk
populations for chronic stress. The psychosocial needs of older adults have been
significantly affected by the pandemic [42].
2.3 COVID-19 and older adults
Older adults have been identified as a high risk population for severe or fatal
responses to COVID-19 [43, 44]. Older adults demonstrate higher peaks of viral
load in response to COVID-19, and are in the highest risk group for comorbidities
including hypertension, cardiovascular disease, diabetes, chronic respiratory dis-
ease, and chronic kidney disease, all of which demonstrate more severe reactions to
COVID-19 and higher rates of fatality [3–6]. Increasing the risks associated with
COVID-19 for older adults, many patients with hypertension, diabetes, and chronic
kidney disease are prescribed medications containing angiotensin-converting
enzyme (ACE) inhibitors and angiotensin II receptor blockers. These medications
upregulate the ACE-2 receptor, which (as discussed above) is the specific receptor
used by the SARS-CoV-2 virus to enter host cells [3, 22, 23].
3. COVID-19 and telehealth
The unprecedented social, economic and healthcare challenges presented by
COVID-19 include the significant strain on medical center resources, and the need
to deliver healthcare at a distance. Telemedicine is a growing methodology that
makes possible timely healthcare delivery while minimizing exposure to protect
medical practitioners and patients. The combination of these factors quickly led to
the rapid adoption of telehealth during the COVID-19 pandemic [45]. Following
system-wide expansion of virtual urgent care staff at a large health system at the
epicenter of the COVID-19 outbreak in the United States, in a six week period
between March 2nd and April 14th 2020 telemedicine visits for urgent healthcare
delivery increased 683 percent. The majority of urgent care visits shifted to tele-
medicine (56.2%), and the utilization of telemedicine was found to be highest
among patients 20 to 44 years of age [46]. U.S. healthcare organizations report
consistent expansion of telehealth adoption during the 3 phases of the U.S.
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COVID-19 pandemic: (1) stay-at-home outpatient care, (2) initial COVID-19
hospital surge, and (3) post-pandemic recovery [47].
A retrospective observational cohort study found an 8729 percent increase in
telehealth visit utilization between March 4 and March 31, 2020 during the COVID-
19 pandemic compared to the same period the previous year (2019), with patients
reporting higher satisfaction for telehealth visits than in-person visits. The authors
of the study concluded that patient satisfaction with telemedicine is high and is not
a barrier toward a paradigm shift away from traditional in-person clinic visits [48].
A literature review of 35 research studies published from 2019 to May 2020
demonstrated the effectiveness of telemedicine as a healthcare delivery platform.
The authors of the literature review concluded that the effectiveness of virtual
healthcare delivery suggests increased integration of digital technologies into
healthcare in the near future [49].
3.1 Disparities in IT utilization
Significant disparities in IT utilization have long been associated with numerous
variables, including ethnicity, age, and socioeconomic status (SES) [15, 17]. People
with intellectual and developmental disabilities also utilize IT at a significantly
lower rate than the general population [50], despite organized efforts to engage
young adults with intellectual disability with social media and other IT [51].
Disparities in IT utilization and access have been described as the digital divide [52],
digital inequality [53, 54], and digital diversity [55].
In addition to variables including ethnicity, disability, and SES, everyone is
affected by the process of aging. In the United States, the number of adults over the
age of 65 is expected to more than double from 46.5 million today to over 98 million
(nearly 25% of the population) by the year 2060 [56, 57]. People over the age of 65
utilize health care at a significantly higher rate than members of younger age
cohorts: 136% of the under 65 group’s use of Emergency Department admissions,
263% for inpatient discharges, and 241% for outpatient office visits [58]. Median
health care costs for people over the age of 65 are 167% the costs for people 64 and
younger [59]. Although older adults’ IT use has increased during the last twenty
years, it continues to trail behind that of younger age cohorts by at least 20%
[15–17], as shown in Table 1.
The current disparity in IT utilization between age groups remains consistent
with that reported over a decade ago by the U.S. Census Bureau and Bureau of
Labor Statistics [15, 18, 55, 60, 61].
3.2 Default utilization of IT by insurers: potential barriers to care
Paradoxically, in the face of a substantial and growing body of research data
demonstrate disparities in IT utilization between groups associated with numerous
variables including age, SES, ethnicity, disability, and educational experience [62],




65 and older 59.2%
Table 1.
IT access and utilization by age: Data from U.S. Census Bureau, 2016.
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over the past decade Medicare and private insurers have increasingly defaulted to
the use of IT (websites, MyChart, text messaging) for communication with patients
[63–65]. Similarly, hospitals, regional health centers, university teaching hospitals,
and local medical clinics have done so [66, 67], in the absence of any data indicating
that the populations they serve have fluency with IT [18].
Based on research data demonstrating disparities in IT utilization [15–18, 50–54],
the default use of IT for communication with all patients may create a barrier to care
for some patient populations. The potential consequence is that patient populations
most in need of health care (including older adults) will find it most difficult to
access [18, 55, 60, 61]. For older adults, CMS tracks potential access to care issues
including economic disparity [68], but it has not addressed IT fluency among older
adults [15–18, 55, 60, 61, 69].
4. Communication with patients and outcomes: assessment of IT
utilization by patient populations
Effective treatment and good outcome rely upon effective communication with
patients. Better communication with patients produces better health outcomes and
increased ratings of satisfaction by patients and providers of care [70, 71]. Para-
doxically, over the past decade health care organizations have defaulted to the use
of IT for patient communication, in the absence of any data supporting patient
utilization of IT for the purpose of communication with health care providers. With
one exception [18, 60, 69, 72], health care protocols, especially for working with
older adults, have not included frequency of internet or IT utilization as a specific
area of assessment or treatment [18, 55, 60, 61, 69, 72–74]. In fact, the American
Psychological Association’s (APA’s) 21 Guidelines for psychologists working with
older adults [75] do not specifically include familiarity with the assessment and
treatment of technology challenges or barriers for older adults as a guideline
[18, 55, 60, 61, 69].
In general, IT has not been included as area of assessment or treatment in
healthcare protocols [18, 55, 60, 61, 69, 72, 74]. Most of the research exploring IT
utilization has come from the IT sector [76–88]. Most IT assessment instruments
assess the person’s perception of their own proficiency with various technologies
[89–95]. These instruments and studies assess factors determining a person’s deci-
sion to use specific technologies, or self-perceived proficiency in using specific
technologies, but none of them assesses the person’s frequency of actual IT use or
perhaps more importantly, the person’s frequency of different kinds of IT use,
information necessary for individualized treatment planning using media that
allows effective communication with the specific patient to facilitate better treat-
ment outcomes [18, 55, 60, 61, 69]. The Functional Assessment of Currently
Employed Technology Scale (FACETS, Appendix 1) [18, 69] was designed specifi-
cally to meet those previously unaddressed needs.
4.1 The Functional Assessment of Currently Employed Technology Scale
(FACETS): description, reliability and validity
The Functional Assessment of Currently Employed Technology Scale (FACETS)
is a 10-item questionnaire that can be completed in one to three minutes. It asks two
questions in each of 5 functional IT domains: Home, Social, E-commerce, Health
Care, and Technical [18, 60, 69]. For each question there are 6 optional answers,
characterizing the respondent’s frequency of use for the specific type of IT
referenced in the question. Higher scores are associated with more frequent
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utilization of IT. A subtotal score for each functional domain is derived from
summating the scores for the two questions in that domain. The combined total of
the subtotal scores from each of the functional domains yields an overall FACETS
score. Higher utilization of IT across domains produces a higher overall FACETS
score. High reliability and validity have been found for FACETS, including multiple
group factor analysis, McDonald’s omega, Cronbach’s alpha coefficient, and
confidence intervals for alpha and omega [69].
4.2 FACETS outcome research
FACETS outcome research has been conducted with populations of varied age,
ethnicity, socio-economic status, household income, and educational level. Respon-
dents who had been diagnosed with, or demonstrated any symptoms of, any
neurocognitive disorder, including Alzheimer’s Disease, Neurocognitive Disorder
with Lewy Bodies, or Vascular Neurocognitive Disease were screened and excluded
from research samples. Among other variables, age groups were used to assess
potential differences in IT utilization between age groups. Age groups were
established based on age per decade, except those younger than 30 and those older
than or equal to 80, each of whom formed their own group. The age groups were
defined as 18 to 29, 30 to 39, 40 to 49, 50 to 59, 60 to 69, 70 to 79, and 80 or older.
The seven age groups are summarized in Table 2.
FACETS outcomes indicate that the strongest effect on IT utilization is for
differences in age. Older respondents consistently score lower in each of the five
FACETS functional domains, and although almost all respondents report access to a
computer (93.3%) and access to the internet (93.5%), the age effect is consistent
with previous data indicating lower internet and IT utilization with increasing age
[15, 17, 18]. FACETS outcome data also indicate that the decline in IT utilization
associated with increasing age advances differently for each domain, suggesting
that IT use is not a homogenous category. The frequency of IT utilization in the
Home domain showed the weakest correlation with age, while frequency of IT
utilization in the Health Care domain showed the highest association with age.
Figure 1 shows the differing patterns of decline in frequency of use for the five
domains.
Although the frequency of IT utilization declines with age in all domains, the
Health Care domain shows the steepest decline, which also occurs earlier than
declines in the other domains. Although previous research indicated that the 20%
discrepancy in IT utilization between younger age cohorts and people aged over 65
has not changed since 1985 [16], FACETS data indicate that discrepancies in the
frequency of IT utilization continue to increase with greater age beyond the age of
Group Age in years
1 18 to 29
2 30 to 39
3 40 to 49
4 50 to 59
5 60 to 69
6 70 to 79
7 80 or older
Table 2.
FACETS age group cutoff points [18].
6
SARS-CoV-2 Origin and COVID-19 Pandemic Across the Globe
65. This is a significant finding, suggesting that people over 65 years of age are not a
homogenous population [18].
Specifically, the frequency of IT utilization for communicating with doctors,
clinics and insurers declines most rapidly with age. In comparison with cohorts up
to age 40, the frequency of IT utilization for communication with insurers and
health care providers declined 28% by age 50, 58% by age 60, 93% by age 70, and
98% by age 80. The demonstrated decline in IT utilization with increasing age is
consistent with earlier research [15–17], but importantly provides more detailed
information about the age at which the rate of decline is greatest, and about prefer-
ences regarding IT utilization for communicating with health care providers at
different ages [18].
5. IT and access to health care
Older adults use IT less than younger age cohorts specifically for accessing health
care. While 95–98% of people under the age of 50 prefer to use IT to communicate
with health care providers and insurers, only 7% of people over the age of 70 and
only 2% of people over the age of 80 do so [18]. These data are shown in Table 3.
The decline in the use of IT for accessing health care with increasing age is more
dramatically apparent when viewed graphically, as in Figure 2.
For example, even though they state that are capable of doing so, adults in age
group 4 (50–59) prefer not to use IT to communicate with insurers or doctors. The
distinction between the respondent’s self-perceived ability to use IT as oppose to
their willingness to use it is especially important in the context of health care, and
has not previously been addressed. FACETS scores for members of older age groups
(aged 70 to 79, and those over 80) whose health care utilization is highest [58, 59]
Figure 1.

















95 98 95 68 40 7 2
Table 3.
% IT utilization of health care by age [18].
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indicate that they almost never utilize IT for communication with insurers or
doctors [18].
5.1 Insurers and IT
The FACETS outcome research data demonstrate that the default use of IT
media (videoconferencing, websites, MyChart, text messaging) by insurers, health
care agencies or providers for communicating with older adult patients is ineffec-
tive, making health care least accessible to the population with the greatest health
care needs, older adults [58, 59]. The FACETS outcome research data also suggest
that the default use of IT by Medicare, private insurers, and providers of health care
for communicating with their patient populations might create a barrier to care and
communication, which in turn might lead to poor health outcomes and lower
satisfaction ratings by patients and providers of care [70, 71].
Despite these data, Medicare and private insurers continue to make increasing
use of websites for communication with patients [63–65, 69]. This trend is shared
by hospitals, regional health centers, university teaching hospitals, and local medi-
cal clinics [66, 67]. This is somewhat alarming, in the absence of any data indicating
that the populations they serve have fluency using the internet or with IT [60, 74].
5.2 Looking forward: IT and younger age cohorts
One of the arguments employed in defense of the increasing use of IT media by
Medicare, insurers and health care providers is that younger age cohorts are more IT
fluent and in time, those lacking IT fluency will no longer be part of the population.
The data demonstrate that this is a flawed premise. For example, the highest inter-
net users in the 1985 U.S. Census Bureau study (age 30–35) are now in the low
internet user category in the U.S. Census Bureau 2016 findings (now aged 63–68).
This finding appears paradoxical, and invites investigation and speculation. Data
from FACETS outcome research suggest that the high IT users of 1985 did not stop
using the internet as they aged, but rather, that adoption of new IT platforms
including those for accessing the internet is lower among increasingly older cohorts.
The lower rate of new IT adoption with age might reflect reduced neuroplasticity
with increasing age [96–98], or detachment from newly introduced technologies
after retirement, and/or lack of access to and/or training in the use of novel IT.
Figure 2.
% frequency of IT use for accessing health care by age group [18].
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Perhaps more importantly, these findings suggests that high IT utilization is tied
less to a specific individual consistently over time than it is tied to a person’s age at
the time novel IT is introduced. Younger people appear to adopt new IT & use it
more consistently than older people, even if the older people were high IT users
when they were young. This is especially relevant in the context of introducing new
or evolving IT for communicating with patient populations. The FACETS outcome
research data indicate that older adults continue frequent use of IT that is familiar,
likely adopted prior to age 40 or 50, while people over the age of 70 demonstrate
much lower utilization of IT introduced after they were in mid-life. Late-life intro-
duction of novel IT appears to dramatically decrease the likelihood that it will be
utilized. In the context of access to care, the introduction of novel IT by Medicare
and health care providers for patient communication with populations over the age
of 70 is likely to represent a future barrier to care even for people who currently
belong to younger age cohorts [18].
5.3 Insurers, IT and other age-related issues
It is important to recall that no symptoms or diagnosis of neurocognitive disor-
der had been observed in any of the participants in the study, including but not
limited to Vascular Neurocognitive Disease, Neurocognitive Disorder with Lewy
Bodies, or Alzheimer’s Disease. In 2015 the global number of people diagnosed with
neurocognitive disease was 46.8 million, and 50 million in 2017. It is expected that
by 2030, the number of people with neurocognitive disease will exceed 75 million,
and by 2050 it will exceed 131.5 million [99–101]. The progressive organic deterio-
ration characteristic of neurocognitive disease correlates with decreasing episodic
memory [102, 103], making it even more challenging for older adults with
neurocognitive illness to learn how to utilize new IT in order to communicate with
health care providers or insurers. The use of IT for communicating with patients in
this population may be neither practical nor realistic, and potentially creates a
barrier to access to care [18].
6. COVID-19, CMS, IT and access to care
Along with people who have serious underlying health conditions, older
adults belong to the cohort most at risk for serious illness reactions to COVID-
19, for whom shelter in place is most strongly recommended. People over age 70
have been encouraged not to leave their homes to purchase groceries or perform
other routine tasks, but only to leave their homes in the case of a physical
emergency [104].
In the context of shelter in place measures to reduce exposure to COVID-19,
between February and April of 2020 the Center for Medicare and Medicaid Services
(CMS) made a number of policy changes intended to make telehealth more acces-
sible to older adults. These include non-enforcement of policies limiting the
patient’s location to approved rural facilities, and the HIPAA compliance of the
audio-visual platforms used for telehealth communications [13, 105]. While these
measures increased access to care to Medicare subscribers with IT fluency, they
failed to address access to care for Medicare subscribers who lack IT fluency. As the
data demonstrate, 93% of people over the age of 70 and 98% of people over the age
of 80 lack IT fluency and do not use the internet to communicate with health care
providers, but instead rely entirely on face-to-face or telephone interactions with
health care providers [18].
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6.1 Advocacy for access to care for older adults during shelter in place
Beginning in March 2020, the American Psychological Association (APA) made
repeated appeals to CMS to allow reimbursement for the use of telephonic psycho-
therapy services during shelter in place [106]. On April 30, 2020, after a series of
refusals, CMS agreed to provide reimbursement for the use of routine psychother-
apy CPT codes for service provided using the telephone [107, 108]. Although the
Medicare policy change is temporary, it makes health care accessible to 95.5% of
Medicare subscribers over the age of 70. The policy change was intended to expire
when the status of COVID-19 was reduced from a national state of emergency, but
legislation is being considered that might make the changes partially or wholly
permanent [74].
6.2 Advocacy for making CMS changes permanent
During shelter in place due to COVID-19, the public was encouraged to utilize
virtual communications, especially videoconferencing, for access to health care.
A growing body of research demonstrates the effectiveness of telemedicine
[48, 109–113]. While this is a viable alternative for younger age cohorts, research
data demonstrate that older adults make very limited use of, and/or have very
limited access to IT for the purpose communicating with health care providers.
While the discrepancy in internet and IT use between younger age cohorts and
people aged over 65 is generally about 20% [16], mean utilization of IT
(internet, web-based interaction) for access to health care by people over the
age of 70 is only about 4.5% [18]. In other words, during shelter in place, 95.5% of
people over the age of 70 relied exclusively on telephonic contact for access to
health care. This finding is of special concern because older adults belong to the
cohort most at risk for serious illness reactions to COVID-19 [104]. Limiting
reimbursement for telephonic health care represents a barrier to care for older
adults [74].
While CMS’s decision to reimburse telephonic psychotherapy [108] is an impor-
tant acknowledgement of the potential barriers to health care IT represents for older
adults and makes health care accessible to an average of 95.5% of Medicare sub-
scribers over the age of 70 [18], the change is temporary and will expire when the
COVID-19 pandemic has been resolved [114]. Making reimbursement for tele-
phonic psychotherapy services a permanent policy will facilitate better communi-
cation with patients, leading to better treatment outcomes [70, 71]. To facilitate
better communication between patients and health care providers, routine assess-
ment of IT utilization might be conducted a part of the standardized initial intake
evaluation with older adults and other populations, in order to determine the most
effective means through which they can access health care. FACETS is a valid and
reliable instrument for assessing which media people use for accessing health care
[18, 69]. Instruments like FACETS can be employed in order to determine the most
effective means through which patients can access health care. Such assessment is
especially important for older adults and other populations with limited IT fluency
and/or access to IT or high-speed internet.
7. Conclusions
Although people over the age of 65 account for only 9% of the world’s popula-
tion, they account for 30 to 40 percent of COVID-19 cases and 80 percent of
COVID-19 deaths [114]. Despite these statistics, people over the age of 65 have been
10
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excluded from more than half of COVID-19 trials seeking effective treatments, and
from all of the vaccine trials [114]. These data speak to the healthcare system’s
tendency to overlook the needs of older adults. Hospitals, community health clinics,
government-funded health agencies and private practices might also conduct simi-
lar assessments to build a larger data base that informs decisions about which media
are most effective for communicating with older adult patients. A larger broad-
based sample might also provide valuable information about the ways in which
older adults access social contact, financial management, and other business func-
tions. At the time of this writing, the COVID-19 pandemic remains unresolved.
However, it is increasingly apparent that older adults rely heavily upon telephonic
access to health care, emphasizing the importance of permanent changes that
liberalize CMS telehealth policy.
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Appendix 1: Functional Assessment of Currently Employed Technology
Scale (FACETS)
Age: _______ Male/ Female Hispanic African American Asian Other
Household Income: < $25,000 < $50,000 < $100,000 < $150,000 > $150,000.
Degree: N/A High School Some college AA Bachelor’s Post graduate.
Access to a computer at home? Yes/ No Access to internet at home? Yes/ No.
Instructions: Check the response that most accurately completes each
A. Home Domain
1. I send email...










2. I find, open & close files in
my computer...
















3. I send text messages using a
smart phone…










4. I post on social media (e.g.,
facebook, twitter)…















































D. Health Care Domain
7. I communicate with my
































Health Care Domain Subtotal
E. Technical Domain

















10. I have reset a modem or
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